Eithan Galun Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

12/2023	IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.
1/2020	Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
1/2019	Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.
1/2013	Natural killer cell-dependent anti-fibrotic pathway in liver injury via Toll-like receptor-9.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eithan Galun Research Topics

Disease

54	Neoplasms (Cancer) 10/2023 - 02/2002
23	Inflammation (Inflammations) 01/2021 - 09/2004
15	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 02/2002
12	Infections 01/2023 - 01/2002
11	Carcinogenesis 10/2023 - 09/2004
6	Fibrosis (Cirrhosis) 12/2023 - 07/2007
6	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2004
5	Ischemia 12/2017 - 11/2004
4	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 01/2013
4	Chronic Hepatitis (Chronic Active Hepatitis) 01/2021 - 07/2013
4	Liver Neoplasms (Liver Cancer) 01/2021 - 06/2009
4	Hypoxia (Hypoxemia) 04/2013 - 02/2004
4	Lung Injury 03/2007 - 11/2004
3	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2020
3	Epilepsy (Aura) 10/2021 - 01/2020
3	Adenocarcinoma 11/2018 - 01/2015
3	Multiple Myeloma 04/2017 - 03/2011
3	Necrosis 08/2015 - 09/2004
3	Hepatitis 07/2013 - 02/2003
2	COVID-19 02/2024 - 01/2023
2	Fatty Liver 12/2023 - 11/2016
2	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 01/2021
2	Hyperthermia 01/2023 - 01/2020
2	Seizures (Absence Seizure) 01/2020 - 01/2020
2	Body Weight (Weight, Body) 01/2020 - 09/2010
2	Anemia 11/2016 - 10/2005
2	Breast Neoplasms (Breast Cancer) 04/2013 - 06/2009
2	Leukemia 03/2011 - 09/2003
2	Hypercapnia 03/2011 - 10/2008
2	Hyperoxia 03/2011 - 10/2008
2	Liver Failure 09/2009 - 11/2002
2	Virus Diseases (Viral Diseases) 07/2007 - 08/2006
2	Liver Diseases (Liver Disease) 07/2007 - 04/2006
2	Prostatic Neoplasms (Prostate Cancer) 04/2007 - 08/2004
2	Viremia 04/2006 - 01/2002
2	Reperfusion Injury 01/2006 - 12/2004
2	Chronic Hepatitis B 11/2003 - 03/2002
1	Cholangiocarcinoma 12/2022
1	Alopecia (Baldness) 01/2022
1	Dermatitis 01/2022

Drug/Important Bio-Agent (IBA)

12	Interleukin-6 (Interleukin 6)IBA 12/2023 - 06/2008
10	CytokinesIBA 01/2023 - 11/2002
9	Proteins (Proteins, Gene)FDA Link 10/2023 - 06/2004
7	salicylhydroxamic acid (SHAM)IBA 10/2023 - 08/2015
7	Chemokine ReceptorsIBA 01/2017 - 08/2004
5	MicroRNAs (MicroRNA)IBA 10/2023 - 06/2009
4	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2002
4	AntibodiesIBA 10/2021 - 08/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2015
4	Small Interfering RNA (siRNA)IBA 09/2015 - 11/2003
4	BKT140IBA 05/2014 - 03/2011
4	LigandsIBA 03/2011 - 08/2004
4	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2007 - 11/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 09/2007
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2022 - 08/2015
3	Cyclin D1IBA 01/2018 - 04/2006
3	InterleukinsIBA 12/2017 - 04/2013
3	Therapeutic UsesIBA 12/2013 - 04/2007
3	H19 long non-coding RNAIBA 04/2010 - 06/2004
3	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2006 - 11/2004
2	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2023
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022 - 04/2013
2	Glutamate Receptors (Glutamate Receptor)IBA 10/2021 - 01/2020
2	CarcinogensIBA 01/2021 - 09/2004
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2006
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021 - 04/2016
2	beta CateninIBA 01/2021 - 11/2007
2	Triglycerides (Triacylglycerol)IBA 01/2020 - 11/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 06/2009
2	4-fluorobenzoyl-TN-14003IBA 01/2018 - 03/2011
2	PlacebosIBA 01/2018 - 04/2016
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 02/2004
2	ChemokinesIBA 01/2017 - 07/2007
2	Erythropoietin FDA Link 11/2016 - 10/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2016 - 09/2004
2	EnzymesIBA 02/2014 - 09/2010
2	Adenosine Triphosphate (ATP)IBA 07/2013 - 11/2004
2	Contrast MediaIBA 04/2013 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 02/2004
2	Untranslated RNA (Noncoding RNA)IBA 06/2009 - 09/2007
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2007 - 04/2006
2	Complementary DNA (cDNA)IBA 04/2007 - 02/2002
2	AntioxidantsIBA 04/2007 - 04/2006
2	Monoclonal AntibodiesIBA 04/2006 - 03/2006
2	Lamivudine (Epivir)FDA Link 04/2006 - 03/2002
2	ElementsIBA 02/2004 - 02/2003
1	Cytokine Receptor gp130IBA 12/2023
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2023
1	VaccinesIBA 01/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022

Therapy/Procedure

15	Therapeutics 07/2023 - 01/2002
10	Radiofrequency Ablation 10/2023 - 01/2015
9	Hepatectomy 01/2017 - 04/2007
3	Aftercare (After-Treatment) 04/2016 - 08/2015
2	Radiotherapy 01/2022 - 03/2016
2	Injections 01/2020 - 11/2016
2	Drug Therapy (Chemotherapy) 01/2018 - 09/2015
2	Transplantation 09/2009 - 09/2003
2	Liver Transplantation 03/2006 - 01/2002